Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1214717 BOSTON, MA

Position in AVXL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$6,718,003
-$483,563 QoQ
Shares Held
2,188,275
+8.2% QoQ
Ownership
2.36%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. AVXL ranks #189 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVXL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,718,003 2,188,275
2025-12-31 $7,201,566 2,022,912
2025-09-30 $18,043,209 2,027,327
2025-06-30 $18,622,509 2,019,795
2025-03-31 $16,858,068 1,964,810
2024-12-31 $20,136,661 1,874,922
2024-09-30 $10,696,570 1,883,199
2024-06-30 $7,727,887 1,831,253
2024-03-31 $8,717,780 1,712,727
2023-12-31 $15,504,538 1,665,364
2023-09-30 $10,302,940 1,572,968
2023-06-30 $12,538,899 1,542,300
2023-03-31 $12,451,164 1,452,878
2022-12-31 $13,014,596 1,405,464
2022-09-30 $13,683,576 1,325,928
2022-06-30 $13,135,342 1,312,222
2022-03-31 $16,099,473 1,307,837
2021-12-31 $22,496,413 1,297,371
2021-09-30 $21,506,056 1,198,109
2021-06-30 $26,462,095 1,157,572
2021-03-31 $15,483,490 1,035,685
2020-12-31 $4,285,396 793,592
2020-09-30 $3,416,217 750,817
2020-06-30 $3,545,967 720,725
2020-03-31 $2,260,380 717,581